Sherif Asmaa E, Alam Rabia, Asif Muhammad, Khan Kashif-Ur-Rehman, Ur Rehman Muhammad Sajid
Department of Pharmacognosy, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-Kharj, Saudi Arabia.
Department of Pharmacognosy, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt.
Front Pharmacol. 2024 Jul 10;15:1326482. doi: 10.3389/fphar.2024.1326482. eCollection 2024.
Uncontrolled inflammation is a crucial factor in the development of many diseases. Anti-inflammatory molecules based on natural sources are being actively studied, among which Retz () has been traditionally used as a paste to heal inflammation. The present study aimed to evaluate the anti-inflammatory, analgesic, and antipyretic potential of an ethanolic extract of through a battery of and models. The ethanolic extract of was prepared by maceration and chemically characterized using high-performance liquid chromatography, which revealed the presence of quercetin, vanillic acid, chlorogenic acid, -coumaric acid, -coumaric acid, ferulic acid, cinnamic acid, and sinapic acid; its antioxidant capacity was then screened with the DPPH assay, which indicated moderate scavenging capacity. A protein denaturation assay was next performed to evaluate the anti-inflammatory potential of , which showed significant inhibition (44.44%) compared to the standard drug (diclofenac sodium), with 89.19% inhibition at a concentration of 1 mg/mL. The safety profile of was evaluated in accordance with the OECD-425 acute toxicity guidelines and found to be safe up to 5 g/kg. The anti-inflammatory potentials of were evaluated at three different doses (125, 250, and 500 mg/kg) in acute (carrageenan-induced edema: 84.60%, histamine-induced paw edema: 84%), sub-chronic (cotton-pellet-induced granuloma: 57.54%), and chronic (complete-Freund's-adjuvant-induced arthritis: 82.2%) models. Our results showed that had significant ( < 0.05) anti-inflammatory effects over diclofenac sodium in the acute and chronic models. Histopathology studies indicated reduced infiltration of paw tissues with inflammatory cells in -treated animals. Similarly, showed significant ( < 0.05) analgesic (yeast-induced-pyrexia model: 23.53%) and antipyretic (acetic-acid-induced writhing model: 51%) effects in a time-dependent manner. studies on the interactions of COX-1 and COX-2 with the eight ligands mentioned earlier confirmed the inhibition of enzymes responsible for inflammation and fever. Based on the findings of the present study, it is concluded that has anti-inflammatory, analgesic, and antipyretic properties that are likely linked to its pharmacologically active phenolic bioactive molecules.
不受控制的炎症是许多疾病发展的关键因素。基于天然来源的抗炎分子正在被积极研究,其中Retz()传统上被用作治疗炎症的糊剂。本研究旨在通过一系列体内和体外模型评估Retz乙醇提取物的抗炎、镇痛和解热潜力。Retz乙醇提取物通过浸渍法制备,并使用高效液相色谱进行化学表征,结果显示其中含有槲皮素、香草酸、绿原酸、对香豆酸、反式对香豆酸、阿魏酸、肉桂酸和芥子酸;然后用DPPH法筛选其抗氧化能力,结果表明其具有中等清除能力。接下来进行蛋白质变性试验以评估Retz的抗炎潜力,结果显示与标准药物双氯芬酸钠相比有显著抑制作用(44.44%),在浓度为1mg/mL时抑制率为89.19%。根据经合组织-425急性毒性指南评估Retz的安全性,发现其在剂量高达5g/kg时是安全的。在急性(角叉菜胶诱导的水肿:84.60%,组胺诱导的爪部水肿:84%)、亚慢性(棉球诱导的肉芽肿:57.54%)和慢性(完全弗氏佐剂诱导的关节炎:82.2%)模型中,以三种不同剂量(125、250和500mg/kg)评估Retz的抗炎潜力。我们的结果表明,在急性和慢性模型中,Retz对双氯芬酸钠具有显著(P<0.05)的抗炎作用。组织病理学研究表明,在接受Retz治疗的动物中,爪部组织炎症细胞浸润减少。同样,Retz在酵母诱导发热模型中显示出显著(P<0.05)的镇痛作用(23.53%),在乙酸诱导扭体模型中显示出显著(P<0.05)的解热作用(51%),且具有时间依赖性。关于COX-1和COX-2与上述八种配体相互作用的研究证实了对负责炎症和发热的酶的抑制作用。基于本研究的结果,得出结论:Retz具有抗炎、镇痛和解热特性,这可能与其具有药理活性的酚类生物活性分子有关。